• Bovine tuberculosis shows genetic diversity throughout Africa  (2018/1/22)
    Bovine tuberculosis shows genetic diversity throughout Africa Bovine tuberculosis (BTB) is an infectious disease caused by Mycobacterium bovis that affects cattle as well as other animals and humans. Now, by combining genotyping M. bovis samples from cows across African countries, researchers have been able to study the diversity and evolution of the disease. The new results are published this week in PLOS Neglected Tropical Diseases. View more
  • New Diagnostics Tool, the Xpert Ultra Assay, Improves Detection of Mycobacterium tuberculosis  (2018/1/18)
    New Diagnostics Tool, the Xpert Ultra Assay, Improves Detection of Mycobacterium tuberculosis Researchers have demonstrated a new, improved version of the Xpert MTB/RIF assay, a test for Rifampicin-resistance (RIF-R). The Xpert “Ultra” assay overcomes the shortcomings of the current Xpert assay to significantly improve tuberculosis detection, especially in patients with pauci-bacillary disease. The new Xpert Ultra assay also provides a more reliable detection of Rifampicin resistance (RIF-R). The research is published this week in mBio, an open-access journal of the American Society for Microbiology. View more
  • New antifungal provides hope in fight against superbugs  (2018/1/16)
    New antifungal provides hope in fight against superbugs Microscopic yeast have been wreaking havoc in hospitals around the world—creeping into catheters, ventilator tubes, and IV lines—and causing deadly invasive infection. One culprit species, Candida auris, is resistant to many antifungals, meaning once a person is infected, there are limited treatment options. But in a recent Antimicrobial Agents and Chemotherapy study, researchers confirmed a new drug compound kills drug-resistant C. auris, both in the laboratory and in a mouse model that mimics human infection. View more
  • Re-programming innate immune cells to fight tuberculosis  (2018/1/16)
    Re-programming innate immune cells to fight tuberculosis Tuberculosis (TB), an infectious disease which attacks the lungs, claims someone's life every 20 seconds and 1.5 million lives worldwide every year. A cure has eluded scientists for more than a century but, now, researchers may have discovered a new weapon to combat this global killer. The team is re-programing - or 'training' - immune cells to kill TB. View more
  • Turning pathogens against each other to prevent drug resistance  (2018/1/11)
    Turning pathogens against each other to prevent drug resistance Limiting a much-needed resource could pit pathogens against one another and prevent the emergence of drug resistance. New research demonstrates that harnessing competition among pathogens inside a patient could extend the life of existing drugs where resistance is already present and prevent resistance to new drugs from emerging. View more
«« « 53/ » »»

خانه چاپ ارسال به دوستان نسخه متنی کوچک کردن متن بزرگ کردن متن دانلود خروجی پی دی اف خروجی میکروسافت ورد
4.8/10 (تعداد آرا 12 نفر )
Copyright © 2011 AASM. All Rights Reserved.